NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $402 | -100.0% | 4,428 | -73.3% | 0.05% | -54.3% |
Q3 2022 | $1,261,000 | +171.2% | 16,591 | +201.3% | 0.12% | +197.4% |
Q2 2022 | $465,000 | +10.5% | 5,506 | +7.1% | 0.04% | +5.4% |
Q3 2021 | $421,000 | -55.4% | 5,142 | -53.4% | 0.04% | -44.8% |
Q1 2021 | $943,000 | +234.4% | 11,028 | +269.0% | 0.07% | +123.3% |
Q4 2020 | $282,000 | -74.8% | 2,989 | -76.8% | 0.03% | -84.4% |
Q3 2020 | $1,121,000 | +70.1% | 12,886 | +70.0% | 0.19% | +276.5% |
Q3 2019 | $659,000 | -35.5% | 7,582 | -28.7% | 0.05% | -12.1% |
Q1 2019 | $1,022,000 | +87.5% | 10,631 | +67.5% | 0.06% | +100.0% |
Q4 2018 | $545,000 | +163.3% | 6,347 | +164.1% | 0.03% | +123.1% |
Q3 2018 | $207,000 | -38.8% | 2,403 | -46.3% | 0.01% | -13.3% |
Q2 2018 | $338,000 | +25.2% | 4,474 | +23.1% | 0.02% | -46.4% |
Q1 2017 | $270,000 | -5.9% | 3,635 | -7.9% | 0.03% | -9.7% |
Q4 2016 | $287,000 | +0.7% | 3,945 | +19.0% | 0.03% | -24.4% |
Q4 2015 | $285,000 | -90.9% | 3,315 | -92.5% | 0.04% | -86.3% |
Q2 2013 | $3,116,000 | – | 44,064 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |